The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control

@inproceedings{Casanova2017TheIO,
  title={The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control},
  author={Francesco Casanova and Damilola D. Adingupu and Fiona Adams and Kim Gooding and Helen C. Looker and Kunihiko Aizawa and Fiona J Dove and Salim Elyas and J. J. F. Belch and Phillip E. Gates and Roberta C. Littleford and Mark Gilchrist and Helen M. Colhoun and A. C. Shore and Faisel Khan and William David Strain},
  booktitle={Cardiovascular diabetology},
  year={2017}
}
BACKGROUND Good glycaemic control in type 2 diabetes (T2DM) protects the microcirculation. Current guidelines suggest glycaemic targets be relaxed in advanced diabetes. We explored whether disease duration or pre-existing macrovascular complications attenuated the association between hyperglycaemia and microvascular function. METHODS 743 participants with T2DM (n = 222), cardiovascular disease (CVD = 183), both (n = 177) or neither (controls = 161) from two centres in the UK, underwent… CONTINUE READING
4 Citations
39 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 39 references

how do we make sense of these new data? Diabetes Ther

  • WD Strain, Smith C. Cardiovascular outcome studies in diabetes
  • 2016;7(2):175–85. Page 11 of 11 Casanova et al…
  • 2017

Similar Papers

Loading similar papers…